during phase 1 , there were remarkable increases in txb2 and 6-keto-pgf1 alpha concentrations in lung lymph and in plasma samples obtained from the pulmonary artery ( pa ) and the left atrium ( la ) .
C0024109
lung
C0034052
pulmonary